Colony Capital, Inc (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The Company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies. The Company has significant holdings in: (a) the healthcare, industrial and hospitality property sectors; (b) Colony Credit Real Estate, Inc (NYSE: CLNC) and NorthStar Realty Europe Corp.
Read More…
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryMortgage REITs
SectorFinance
Phone310-282-8820
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.67 billion
Profitability
Miscellaneous
Employees400
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Colony Capital (NYSE:CLNY) Frequently Asked Questions
What is Colony Capital's stock symbol?
Colony Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLNY."
How often does Colony Capital pay dividends? What is the dividend yield for Colony Capital?
Colony Capital announced a quarterly dividend on Monday, May 13th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.11 per share on Monday, July 15th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 9.89%. The ex-dividend date is Thursday, June 27th. View Colony Capital's Dividend History.
How were Colony Capital's earnings last quarter?
Colony Capital Inc (NYSE:CLNY) issued its quarterly earnings data on Friday, August, 9th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by $0.03. The real estate investment trust earned $573.40 million during the quarter, compared to analyst estimates of $669.45 million. Colony Capital had a negative net margin of 36.96% and a negative return on equity of 9.60%. The business's revenue for the quarter was down 16.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.18 earnings per share. View Colony Capital's Earnings History.
When is Colony Capital's next earnings date?
What price target have analysts set for CLNY?
2 equities research analysts have issued 1 year price objectives for Colony Capital's shares. Their predictions range from $8.00 to $9.00. On average, they expect Colony Capital's stock price to reach $8.50 in the next twelve months. This suggests a possible upside of 91.0% from the stock's current price. View Analyst Price Targets for Colony Capital.
What is the consensus analysts' recommendation for Colony Capital?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colony Capital in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Colony Capital.
Has Colony Capital been receiving favorable news coverage?
News coverage about CLNY stock has been trending positive this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colony Capital earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned headlines about the real estate investment trust a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the immediate future. View News Stories for Colony Capital.
Are investors shorting Colony Capital?
Colony Capital saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 9,927,500 shares, an increase of 30.1% from the June 30th total of 7,630,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the days-to-cover ratio is currently 4.2 days. Currently, 2.2% of the company's stock are short sold. View Colony Capital's Current Options Chain.
Who are some of Colony Capital's key competitors?
Some companies that are related to Colony Capital include Omega Healthcare Investors (OHI), Store Capital (STOR), Medical Properties Trust (MPW), Gaming and Leisure Properties (GLPI), Kilroy Realty (KRC), Kimco Realty (KIM), CyrusOne (CONE), Liberty Property Trust (LPT), Lamar Advertising (LAMR), Apartment Investment and Management (AIV), American Homes 4 Rent (AMH), Douglas Emmett (DEI), AmeriCold Realty Trust (COLD), CubeSmart (CUBE) and Starwood Property Trust (STWD).
What other stocks do shareholders of Colony Capital own?
Who are Colony Capital's key executives?
Colony Capital's management team includes the folowing people:
- Mr. Thomas Joseph Barrack Jr., Founder, Exec. Chairman & CEO (Age 70)
- Mr. Darren J. Tangen, Pres (Age 48)
- Mr. Kevin P. Traenkle, Exec. VP & Chief Investment Officer (Age 49)
- Mr. Mark Melvin Hedstrom CPA, Exec. VP, COO & CFO (Age 60)
- Mr. Neale W. Redington, MD & Chief Accounting Officer (Age 52)
Who are Colony Capital's major shareholders?
Colony Capital's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (14.04%), BlackRock Inc. (6.73%), Caisse DE Depot ET Placement DU Quebec (6.52%), Fosun International Ltd (1.39%), Charles Schwab Investment Management Inc. (0.95%) and Nuveen Asset Management LLC (0.93%). Company insiders that own Colony Capital stock include Neale Redington and Raymond C Mikulich. View Institutional Ownership Trends for Colony Capital.
Which major investors are selling Colony Capital stock?
CLNY stock was sold by a variety of institutional investors in the last quarter, including Fosun International Ltd, BlackRock Inc., Tensile Capital Management LLC, Bank of America Corp DE, Asset Management One Co. Ltd., Jennison Associates LLC, Jennison Associates LLC and Wells Fargo & Company MN. View Insider Buying and Selling for Colony Capital.
Which major investors are buying Colony Capital stock?
CLNY stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, Charles Schwab Investment Management Inc., Renaissance Technologies LLC, Prudential Financial Inc., Parametric Portfolio Associates LLC, First Trust Advisors LP and JPMorgan Chase & Co.. View Insider Buying and Selling for Colony Capital.
How do I buy shares of Colony Capital?
Shares of CLNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Colony Capital's stock price today?
One share of CLNY stock can currently be purchased for approximately $4.45.
How big of a company is Colony Capital?
Colony Capital has a market capitalization of $2.17 billion and generates $2.67 billion in revenue each year. The real estate investment trust earns $-519,610,000.00 in net income (profit) each year or $0.62 on an earnings per share basis. Colony Capital employs 400 workers across the globe.View Additional Information About Colony Capital.
What is Colony Capital's official website?
How can I contact Colony Capital?
Colony Capital's mailing address is 515 SOUTH FLOWER STREET 44TH FLOOR, LOS ANGELES CA, 90071. The real estate investment trust can be reached via phone at 310-282-8820 or via email at [email protected]
MarketBeat Community Rating for Colony Capital (NYSE CLNY)
MarketBeat's community ratings are surveys of what our community members think about Colony Capital and other stocks. Vote "Outperform" if you believe CLNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
